Efficacy of CapeOX plus Cetuximab Treatment as a First-Line Therapy for Patients with Extended RAS/BRAF/PIK3CA Wild-Type Advanced or Metastatic Colorectal Cancer

Background: Oxaliplatin and capecitabine (CapeOX) combined with cetuximab is rarely used to treat advanced and metastatic colorectal cancer (mCRC). The present study aimed to clarify the clinical benefits of this treatment regimen when used as a first-line therapy in patients with expanded RAS/BRAF/...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Cancer
Main Authors: Iwamoto, Shigeyoshi, Maeda, Hiromichi, Hazama, Shoichi, Oba, Koji, Okayama, Naoko, Suehiro, Yutaka, Yamasaki, Takahiro, Suzuki, Nobuaki, Nagano, Hiroaki, Sakamoto, Junichi, Mishima, Hideyuki, Nagata, Naoki
Format: Artigo
Sprog:Inglês
Udgivet: Ivyspring International Publisher 2018
Fag:
Research Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6277612/
https://ncbi.nlm.nih.gov/pubmed/30519308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.26840
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker